Royal (Wuxi) Bio-pharmaceutical Co.
Latest round
- Series A
Last raised
- Jun 2012
Total raised
- Undisclosed
Investors
- 1
About Royal (Wuxi) Bio-pharmaceutical Co.
, Ltd is a biopharmaceutical company that focuses on the development, manufacture and marketing of medicines cover treatment, precautionary and biological reagent area. At present, the company covers an area of more than 100000 square meters, and the total investment in phase I is 25 million dollars. The existing scientific research personnel account for 70% of the company's employees. The company has developed the freeze dried meningococcal conjugate vaccine of group A and group C for children from 6 months to 2 years old.
Who invested in Royal (Wuxi) Bio-pharmaceutical Co.
1 investor across 1 round
See all investors in Royal (Wuxi) Bio-pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 14, 2012
Amount
Undisclosed
Investors
Questions about Royal (Wuxi) Bio-pharmaceutical Co.
Who invested in Royal (Wuxi) Bio-pharmaceutical Co.?
Royal (Wuxi) Bio-pharmaceutical Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Royal (Wuxi) Bio-pharmaceutical Co. raised?
Royal (Wuxi) Bio-pharmaceutical Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Royal (Wuxi) Bio-pharmaceutical Co. last raise money?
Royal (Wuxi) Bio-pharmaceutical Co.'s most recent round on record is a Series A, in Jun 2012.
What does Royal (Wuxi) Bio-pharmaceutical Co. do?
, Ltd is a biopharmaceutical company that focuses on the development, manufacture and marketing of medicines cover treatment, precautionary and biological reagent area.
Where is Royal (Wuxi) Bio-pharmaceutical Co. headquartered?
Royal (Wuxi) Bio-pharmaceutical Co. is headquartered in Wuxi, China.
Which VCs invest in companies like Royal (Wuxi) Bio-pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Royal (Wuxi) Bio-pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Royal (Wuxi) Bio-pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.